1-167776122-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003953.6(MPZL1):c.664G>A(p.Asp222Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000298 in 1,612,502 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003953.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MPZL1 | NM_003953.6 | c.664G>A | p.Asp222Asn | missense_variant | 5/6 | ENST00000359523.7 | NP_003944.1 | |
MPZL1 | XM_047433610.1 | c.292G>A | p.Asp98Asn | missense_variant | 6/7 | XP_047289566.1 | ||
MPZL1 | NM_024569.5 | c.605+2754G>A | intron_variant | NP_078845.3 | ||||
MPZL1 | NM_001146191.2 | c.258+10373G>A | intron_variant | NP_001139663.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152116Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 250458Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135424
GnomAD4 exome AF: 0.0000274 AC: 40AN: 1460386Hom.: 0 Cov.: 30 AF XY: 0.0000303 AC XY: 22AN XY: 726508
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152116Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74326
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 21, 2024 | The c.664G>A (p.D222N) alteration is located in exon 5 (coding exon 5) of the MPZL1 gene. This alteration results from a G to A substitution at nucleotide position 664, causing the aspartic acid (D) at amino acid position 222 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at